Depression Clinical Trials in Baltimore, Maryland

8 studies are recruiting for depression in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

   This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve qual…

   Stage

   EARLY_Phase 1

   Ages

   18 to 85

   Site

   Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04123314 on ClinicalTrials.gov

2. Psilocybin in Chronic Low Back Pain and Depression

   This study seeks to provide insight on psilocybin's effects on mechanisms of chronic pain among patients with co-morbid chronic low back pain and depression (CLBP+D). Participants will receive either a single high-dose of psilocybin (25mg absolute dose) or methylphenidate (40mg absolute dose). Part…

   Stage

   Phase 1

   Ages

   21 to 80

   Site

   Johns Hopkins University School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT06355414 on ClinicalTrials.gov

3. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   Johns Hopkins Medicine, Baltimore, Maryland

   Locations

   69 in total

   Run by

   Cybin IRL Limited

   See if you can join NCT06793397 on ClinicalTrials.gov

4. E-Mindfulness Approaches for Living After Breast Cancer

   NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants wi…

   Stage

   Phase 3

   Ages

   18 to 50

   Site

   Maryland Proton Treatment Center, Baltimore, Maryland

   Locations

   383 in total

   Run by

   NRG Oncology

   See if you can join NCT06748222 on ClinicalTrials.gov

5. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

   Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of dep…

   Stage

   Phase 3

   Ages

   10 to 17

   Site

   The Kennedy Krieger Institute /ID# 226509, Baltimore, Maryland

   Locations

   81 in total

   Run by

   AbbVie

   See if you can join NCT04777357 on ClinicalTrials.gov

6. CAPABLE Transplant

   The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist populatio…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Johns Hopkins School of Nursing, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT06326905 on ClinicalTrials.gov

7. Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study

   The purpose of the study is to evaluate a trauma informed digital multicomponent intervention design to improve health and safety outcomes for women with lifetime exposures to violence and co-occurring PTSD and/or depression symptoms

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins University, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT07227337 on ClinicalTrials.gov

8. Glucose Variability and Cognition in Prediabetes

   This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.

   Stage

   Not phased

   Ages

   50 and older

   Site

   Baltimore VA Geriatric Research Education and Clinical Center (GRECC), Baltimore, Maryland

   Run by

   University of Maryland, Baltimore

   See if you can join NCT04201600 on ClinicalTrials.gov